GMJ Briefs
Frontline Innovation: How NHS Teams are Revolutionizing Patient Care Delivery
NHS Excellence Awards recognise transformative innovations by frontline teams that improve both patient outcomes and system sustainability across England.
Malawi Study Reveals Substantial Hidden Disease Burden in Childhood Pneumonia
Fourteen percent of children with pneumonia in Malawi require hospitalisation, yet current clinical tools miss many high-risk cases.
Three Evidence-Based Changes Your Body Undergoes During Intermittent Fasting
Research identifies three key biological changes during intermittent fasting: reduced appetite-control brain activity, healthier gut bacteria, and sustained weight loss…
4.5 Million Korean Adults Reveal E-Cigarette Risk: Complete Cessation Optimal for Cancer Prevention
E-cigarette use after smoking cessation linked to higher lung cancer incidence in 4.5 million Korean adults; complete cessation remains optimal…
What Clinicians Should Know: IMA401 Phase 1a Trial Results and Implications
Phase 1a trial of IMA401 demonstrates promising safety, efficacy signals, and synergistic potential with checkpoint inhibitors for refractory solid tumors.
Landmark Study Questions Decades of Bicarbonate Use in Critical Care
Large-scale trial finds sodium bicarbonate offers no mortality advantage in critically ill patients with shock, challenging decades of standard ICU…
300,000 Annual Cases Drive Urgent Need for Lassa Fever Prevention Strategy
300,000 annual Lassa fever cases in West Africa could be prevented by new vaccine showing promise in human trials.
What Clinicians Need to Know: Triple-Drug Therapy Advances Prostate Cancer Management
Triple-drug therapy shows superior survival benefits across patient populations with advanced prostate cancer, reshaping clinical treatment considerations.